Anzeige
Mehr »
Login
Mittwoch, 04.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 02.06.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
02.06.ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer156Evorpacept in combination with PADCEV®, an approved antibody-drug conjugate ("ADC"), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast with...
► Artikel lesen
02.06.Nanobiotix S.A.: Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy231Data show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; "ITT") who received RT-activated NBTXR3 followed by anti-PD-1 as a second-or-later...
► Artikel lesen
02.06.Celldex Therapeutics, Inc.: Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2024124- Clinically meaningful and statistically significant improvements across multiple angioedema measurements and barzolvolimab dose groups -- Sustained activity with rapid onset within 2 weeks -- Data...
► Artikel lesen
02.06.NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Enterprise Software Support for NVIDIA IGX With Holoscan631TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- To address the increasing need for real-time AI computing at the industrial edge, NVIDIA today announced the general software availability...
► Artikel lesen
02.06.NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCs122TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced new NVIDIA RTX technology to power AI assistants and digital humans running on new GeForce RTX AI laptops. NVIDIA...
► Artikel lesen
02.06.NVIDIA Supercharges Ethernet Networking for Generative AI274TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced widespread adoption of the NVIDIA Spectrum-X Ethernet networking platform as well as an accelerated product release...
► Artikel lesen
02.06.NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World's Millions of Developers Into Generative AI Developers168150+ Partners Across Every Layer of AI Ecosystem Embedding NIM Inference Microservices to Speed Enterprise AI Application Deployments From Weeks to MinutesNVIDIA Developer Program Members Gain Free...
► Artikel lesen
02.06.NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI Avatars162TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced the general availability of NVIDIA ACE generative AI microservices to accelerate the next wave of digital humans...
► Artikel lesen
02.06.Intellia Therapeutics, Inc.: Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)288Extended follow-up data reaching over two years in the earliest patients dosed reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE)Eight...
► Artikel lesen
02.06.BioCryst Pharmaceuticals, Inc.: BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO (berotralstat) Treatment172RESEARCH TRIANGLE PARK, N.C., June 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence showing that patients with hereditary angioedema...
► Artikel lesen
02.06.European Academy of Allergy and Clinical Immunology: Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year454The HEAD registry, with nearly 800 patients, serves to evaluate the economic and social impact of allergies at a European level VALENCIA, Spain, June 02, 2024 (GLOBE NEWSWIRE) -- Allergic diseases...
► Artikel lesen
02.06.Merus N.V.: Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting670UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 02, 2024(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies...
► Artikel lesen
02.06.King Faisal Specialist Hospital & Research Centre: KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering546JEDDAH, Saudi Arabia, June 02, 2024 (GLOBE NEWSWIRE) -- In an era where healthcare innovation is paramount, KFSHRC Jeddah has made headway in the treatment of severe Xanthoma through the deployment...
► Artikel lesen
02.06.ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth646Technology focused company streamlines operations while focused on its digital platformAustin, Texas, June 02, 2024 (GLOBE NEWSWIRE) -- ePac Flexible Packaging, founded in 2016 as the world's first...
► Artikel lesen
02.06.Heineken® Celebrates Thousands of 'Real Hardcore Fans' by Helping Them Take Part in the UEFA Champions League Final Trophy Celebrations For The First Time Ever936Heineken® says cheers to the Real Hardcore Fans as thousands of fans faces adorn the celebration confetti during the UEFA Champions League Final 2024 Trophy Lift at Wembley LONDON, June 01...
► Artikel lesen